Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CNPPD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SUGP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BLVRA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMAD6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BCL2L11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TEX15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PARD3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WBSCR22 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FOXP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SHC4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STX5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF207 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBMS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SERINC3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C17orf80 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GAGE12D - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCZ1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DNAJB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on